Reactive arthritis before and after the onset of the COVID-19 pandemic

D Bekaryssova, M Yessirkepov, O Zimba… - Clinical …, 2022 - Springer
Most accepted definitions of reactive arthritis (ReA) consider it a type of spondyloarthritis
(SpA) precipitated by a gut or urogenital infection. A wider definition considers any arthritis …

[HTML][HTML] Knowledge and perceptions of reactive arthritis diagnosis and management among healthcare workers during the COVID-19 pandemic: online survey

D Bekaryssova, M Joshi, L Gupta… - Journal of Korean …, 2022 - synapse.koreamed.org
Background Reactive arthritis (ReA) is an often neglected disease that received some
attention during the coronavirus disease 2019 (COVID-19) pandemic. There is some …

Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory …

Q Wei, PJ Mease, M Chiorean, L Iles-Shih… - The Lancet Digital …, 2024 - thelancet.com
Background In the context of immune-mediated inflammatory diseases (IMIDs), COVID-19
outcomes are incompletely understood and vary considerably depending on the patient …

[HTML][HTML] Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a …

Q Wei, PJ Mease, M Chiorean, L Iles-Shih, WF Matos… - Medrxiv, 2023 - ncbi.nlm.nih.gov
Background COVID-19 outcomes, in the context of immune-mediated inflammatory diseases
(IMIDs), are incompletely understood. Reported outcomes vary considerably depending on …

Factors associated with COVID-19 severity in patients with spondyloarthritis: Results of the French RMD COVID-19 cohort

L Perrot, L Boyer, RM Flipo, H Marotte, E Pertuiset… - Joint Bone Spine, 2023 - Elsevier
Objectives The objective of the current study was to evaluate the severity of COVID-19 and
identify factors associated with severe disease outcomes in patients with spondyloarthritis …

Influence of accepting basic antirheumatic therapy for ankylosing spondyloarthritis on the clinical course Covid-19

NM Abdurakhmanova… - ACADEMICIA: An …, 2022 - indianjournals.com
The article presents data from our ownstudies on the clinical course of COVID-19 in
patientswith ankylosing spondylitis while receiving basic therapy. Patients were divided into …

Interplay between COVID-19 and Secukinumab treatment in Spondylarthritis patients during the omicron surge: a retrospective cohort study

T Wu, Y Li, D Huang, Y Wu, X Liang, L Cheng… - …, 2024 - Taylor & Francis
The objective of this retrospective cohort study was to assess the relationship between
Corona Disease 2019 (COVID-19) and Secukinumab treatment in patients with …

HLAB27 may confer protection to COVID-19 in generalized vitiligo patients from South Gujarat population

PS Giri, R Bhimani, NC Laddha… - … , Nucleotides & Nucleic …, 2024 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), while generalized vitiligo (GV) is an autoimmune …

Microorganisms in the Pathogenesis and Management of Spondyloarthritis

Z Mukhatayev, A Sharip, A Nurgozhina… - Role of Microorganisms …, 2022 - Springer
Spondyloarthritis is an umbrella term for a group of inflammatory diseases of the joints and
spine. The group includes ankylosing spondylitis, reactive arthritis, psoriatic arthritis, arthritis …

Аксиальный спондилоартрит и COVID-19: течение, взаимодействие, исходы и роль вакцинации

ШФ Эрдес, БС Белов - Современная ревматология, 2023 - mrj.ima-press.net
Аннотация В обзоре проанализированы данные о течении и исходах аксиального
спондилоартрита (аксСпА), накопленные за предшествующие 2, 5 года пандемии …